Back to search
FDAFDA · Food and drugs·Recall number D-0720-2018

LIPO-B Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

Published May 2, 2018 · Recall initiated: April 5, 2018

Summary

FDA records drug Class II recall D-0720-2018, published May 2, 2018 and initiated April 5, 2018. Recalling firm: Coastal Meds, LLC.; Status: Terminated; Reported quantity: 3959 vials; Lot: Lots: LB/100517 Discard by 4/3/2018; LB/111717 Discard by 5/16/2018; LB/120717 Discard by 6/5/2018; LB/010418 Discard by 7/3/2018; LB/012618 Discard by 7/25/2018; LB/022118 Discard by 8/20/2018; CALB/012918 Discard by 3/30/2018; CALB/021218 Discard by 4/13/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate matter. Recall due to presence of unknown particulate matter.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Coastal Meds, LLC.
Distributor
Nationwide in the USA
Lot
Lots: LB/100517 Discard by 4/3/2018; LB/111717 Discard by 5/16/2018; LB/120717 Discard by 6/5/2018; LB/010418 Discard by 7/3/2018; LB/012618 Discard by 7/25/2018; LB/022118 Discard by 8/20/2018; CALB/012918 Discard by 3/30/2018; CALB/021218 Discard by 4/13/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LIPO-B Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532 recalled?

Yes. FDA published recall D-0720-2018 on May 2, 2018. Reported hazard: Presence of Particulate matter. Recall due to presence of unknown particulate matter.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail